161 related articles for article (PubMed ID: 37588759)
1. Preclinical Characterization of 22-(4'-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis
Iksen I; Seephan S; Limprasutr V; Sinsook S; Buaban K; Chamni S; Pongrakhananon V
ACS Pharmacol Transl Sci; 2023 Aug; 6(8):1143-1154. PubMed ID: 37588759
[TBL] [Abstract][Full Text] [Related]
2. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge
Iksen I; Sinsook S; Wattanathamsan O; Buaban K; Chamni S; Pongrakhananon V
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558080
[TBL] [Abstract][Full Text] [Related]
3. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.
Zhang E; Feng X; Liu F; Zhang P; Liang J; Tang X
PLoS One; 2014; 9(7):e103440. PubMed ID: 25058399
[TBL] [Abstract][Full Text] [Related]
4. Cytochalasin H Inhibits Angiogenesis
Ma Y; Xiu Z; Zhou Z; Huang B; Liu J; Wu X; Li S; Tang X
J Cancer; 2019; 10(9):1997-2005. PubMed ID: 31205560
[TBL] [Abstract][Full Text] [Related]
5. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS
Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
8. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
Chen MC; Hsu WL; Hwang PA; Chou TC
Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287
[TBL] [Abstract][Full Text] [Related]
9. Jorunnamycin A from
Ecoy GAU; Chamni S; Suwanborirux K; Chanvorachote P; Chaotham C
J Nat Prod; 2019 Jul; 82(7):1861-1873. PubMed ID: 31260310
[TBL] [Abstract][Full Text] [Related]
10. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
11. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
[TBL] [Abstract][Full Text] [Related]
12. Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells.
Tang XD; Zhou X; Zhou KY
Acta Pharmacol Sin; 2009 May; 30(5):605-16. PubMed ID: 19349962
[TBL] [Abstract][Full Text] [Related]
13. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
14. Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells.
Shen L; Zhang SQ; Liu L; Sun Y; Wu YX; Xie LP; Liu JC
Med Sci Monit; 2017 Jan; 23():223-237. PubMed ID: 28087861
[TBL] [Abstract][Full Text] [Related]
15. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
[TBL] [Abstract][Full Text] [Related]
16. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
Saraswati S; Kumar S; Alhaider AA
Mol Cancer; 2013 Nov; 12():147. PubMed ID: 24261856
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation.
Zhang L; Chen C; Duanmu J; Wu Y; Tao J; Yang A; Yin X; Xiong B; Gu J; Li C; Liu Z
Int Immunopharmacol; 2018 Dec; 65():429-437. PubMed ID: 30388517
[TBL] [Abstract][Full Text] [Related]
19. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells.
Sumkhemthong S; Chamni S; Ecoy GU; Taweecheep P; Suwanborirux K; Prompetchara E; Chanvorachote P; Chaotham C
Mar Drugs; 2021 May; 19(5):. PubMed ID: 34063628
[TBL] [Abstract][Full Text] [Related]
20. Novel Nargenicin A1 Analog Inhibits Angiogenesis by Downregulating the Endothelial VEGF/VEGFR2 Signaling and Tumoral HIF-1α/VEGF Pathway.
Han JM; Choi YS; Dhakal D; Sohng JK; Jung HJ
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32751120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]